-
- U.S. FDA Grants Priority Review to BeOne Medicines’ BRUKINSA Combination in First-Line Mantle Cell Lymphoma
- BeOne Medicines Ltd. (Nasdaq: ONC; HKEX: 06160; SSE: 688235), a global oncology company, today announced that the U.S. Food and Drug Administration (FDA) has accepted and granted Priority Review to the suppl...
- 11월 06일 14:20
-
- Zenitar Announces Initiation of International Randomized Study of Flonoltinib Maleate in Patients with Myelofibrosis and Related American Society of Hematology 2026 Meeting Presentations
- Chengdu Zenitar Biomedical Technology Co., Ltd. (Zenitar) is developing flonoltinib maleate (FM), a first-in-class oral JAK2/FLT3/CDK6 inhibitor for myeloproliferative neoplasms (MPNs), including myelofibros...
- 11월 06일 14:10
-
- iConnections and Preqin, a Part of BlackRock, Announce Collaboration to Bring Institutional Data to Violet, an AI-Powered Capital Introduction Platform
- iConnections today announced a collaboration with Preqin, a part of BlackRock, that brings one of the industry‘s leading sources of private markets data and intelligence— spanning fund managers, institutiona...
- 11월 06일 15:30
-
- SkyDrive Signs MOU with Goyang Special City and Verty to Accelerate Commercial eVTOL Deployment in South Korea
- SkyDrive Inc. (“SkyDrive”), a leading compact eVTOL aircraft (*1) developer based in Japan, announced that it has signed a tripartite memorandum of understanding (MOU) with Goyang Special City, a prominent S...
- 11월 06일 14:00
